ABC.L Share News (ABC)

Abcam agrees AxioMx takeover

(ShareCast News) - Protein research tools producer Abcam has reached an agreement to acquire monoclonal antibodies producer AxioMx in a deal worth up to $45m (£29.7m). The London-listed company said it will pay $20m upfront for AxioMx, with a further $25m due based on the US-based company achieve ce

Abcam Strikes Deal To Buy US-Based AxioMx For Up To USD45 Million

Dividends Calendar - Week Ahead

Abcam On Course To Meet Financial 2016 Expectations, Plans Investments

AGM, EGM Calendar - Week Ahead

DIRECTOR DEALINGS: ABCAM Company Secretary Smith Buys Shares

LONDON BRIEFING: Chinese Industrial Production Disappoints

ABCAM CFO To Step Down As It Says New Year Has Started Well

Horizon Discovery Enters Licence, Supply Agreement With Abcam

Earnings, Trading Statements Calendar - Week Ahead

Earnings, Trading Statements Calendar - Week Ahead

Abcam "back on track" with strong full-year revenues

(ShareCast News) - Antibodies and protein research products producer Abcam said it has been attracting and retaining consumers to its business and delivering market revenue growth. The group added the year ended 30 June 2015, was a successful one driven by its strategy, with revenues expected to ris

WINNERS AND LOSERS SUMMARY: Unilever, Kingfisher Up As Aberdeen, SSE Drop

Abcam Expects To Post 12% Revenue Growth For Full Year

BROKER RATINGS SUMMARY: Berenberg Raises AstraZeneca To Buy from Hold